Sally Siegfried

DNP Doctor of Nursing Practice,  Cleveland Clinic 

Location: Germany

Consulting Services

Pharma-CRO-Device Data Science-Bioinformatics Sales and Marketing Research Consulting Journal Manuscript

Areas Of Interest

Posttraumatic Hypersomnias Noncommunicable Diseases Crouzons Disease Vasovasostomies Glioblastoma with Sarcomatous Component Vision Test RPTP-sigma Prosthesis Migrations Synthetase, Farnesyl Diphosphate Electroversion, Cardiac Distance, Social Polyarthralgia Spleen Necrosis Viruses Time Intervals, Systolic Receptor, Insulin-Like-Growth-Factor II Subtalar Joint cuniculi, Nosema Syndrome X, Dysmetabolic Monoxide, Carbon Disorder, Late-Onset alpha,alpha-Dipyridyl PDE 3 Inhibitors Hemorrhage, Intracerebral Cytidine Monophosphate N Acetylneuraminic Acid Cortical Amygdaloid Nucleus Chains, Ig delta Nutritional Physiology, Elder Deficiency of C1 Esterase Inhibitor Pre Par Luminescence Measurements Cranial Nerve, Second cAMP-Dependent Protein Kinase Esophagoscopes FR-17027 MK 217 Retroflexions, Uterine Lactotroph ZIFT Gymnotids Rhesus Blood-Group Systems

Professional Narrative

Dr. Sally Siegfried was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Siegfried has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Amgen 2011
Senior Director, Mayo Clinic 1993

Education

Doctor of osteopathic medicine, Perelman School of Medicine 2014
Bachelor of science in nursing, Weill Medical College 2007

Referees


Publications

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :